Abstract
Interferon-beta (IFN-β) is a cytokine with anti-viral, anti-proliferative, and immunomodulatory effects. In this study, we investigated the effects of IFN-β on the induction of autophagy and the relationships among autophagy, growth inhibition, and apoptosis induced by IFN-β in human glioma cells. We found that IFN-β induced autophagosome formation and conversion of microtubule associated protein 1 light chain 3 (LC3) protein, whereas it inhibited cell growth through caspase-dependent cell apoptosis. The Akt/mTOR signaling pathway was involved in autophagy induced by IFN-β. A dose- and time-dependent increase of p-ERK 1/2 expression was also observed in human glioma cells treated with IFN-β. Autophagy induced by IFN-β was suppressed when p-ERK1/2 was impaired by treatment with U0126. We also demonstrated that suppression of autophagy significantly enhanced growth inhibition and cell apoptosis induced by IFN-β, whereas inhibition of caspase-dependent cell apoptosis impaired autophagy induced by IFN-β. Collectively, these findings indicated that autophagy induced by IFN-β was associated with the Akt/mTOR and ERK 1/2 signaling pathways, and inhibition of autophagy could enhance the growth inhibitory effects of IFN-β and increase apoptosis in human glioma cells. Together, these findings support the possibility that autophagy inhibitors may improve IFN-β therapy for gliomas.
Similar content being viewed by others
References
Natsume A, Ishii D, Wakabayashi T, Tsuno T, Hatano H, Mizuno M, Yoshida J (2005) IFN-beta down-regulates the expression of DNA repair gene MGMT and sensitizes resistant glioma cells to temozolomide. Cancer Res 65(17):7573–7579. doi:10.1158/0008-5472.CAN-05-0036
Stewart LA (2002) Chemotherapy in adult high-grade glioma: a systematic review and meta-analysis of individual patient data from 12 randomised trials. Lancet 359(9311):1011–1018
Okazaki T, Kageji T, Kuwayama K, Kitazato KT, Mure H, Hara K, Morigaki R, Mizobuchi Y, Matsuzaki K, Nagahiro S (2012) Up-regulation of endogenous PML induced by a combination of interferon-beta and temozolomide enhances p73/YAP-mediated apoptosis in glioblastoma. Cancer Lett 323(2):199–207. doi:10.1016/j.canlet.2012.04.013
Auffinger B, Thaci B, Nigam P, Rincon E, Cheng Y, Lesniak MS (2012) New therapeutic approaches for malignant glioma: in search of the Rosetta stone. F1000 Med Rep 4:18. doi:10.3410/M4-18
Natsume A, Wakabayashi T, Ishii D, Maruta H, Fujii M, Shimato S, Ito M, Yoshida J (2008) A combination of IFN-beta and temozolomide in human glioma xenograft models: implication of p53-mediated MGMT downregulation. Cancer Chemother Pharmacol 61(4):653–659. doi:10.1007/s00280-007-0520-x
Saito R, Mizuno M, Hatano M, Kumabe T, Yoshimoto T, Yoshida J (2004) Two different mechanisms of apoptosis resistance observed in interferon-beta induced apoptosis of human glioma cells. J Neurooncol 67(3):273–280
Yoshino A, Ogino A, Yachi K, Ohta T, Fukushima T, Watanabe T, Katayama Y, Okamoto Y, Naruse N, Sano E (2009) Effect of IFN-beta on human glioma cell lines with temozolomide resistance. Int J Oncol 35(1):139–148
Mahoney E, Lucas DM, Gupta SV, Wagner AJ, Herman SE, Smith LL, Yeh YY, Andritsos L, Jones JA, Flynn JM, Blum KA, Zhang X, Lehman A, Kong H, Gurcan M, Grever MR, Johnson AJ, Byrd JC (2012) ER stress and autophagy: new discoveries in the mechanism of action and drug resistance of the cyclin-dependent kinase inhibitor flavopiridol. Blood 120(6):1262–1273. doi:10.1182/blood-2011-12-400184
Zou Z, Yuan Z, Zhang Q, Long Z, Chen J, Tang Z, Zhu Y, Chen S, Xu J, Yan M, Wang J, Liu Q (2012) Aurora kinase A inhibition-induced autophagy triggers drug resistance in breast cancer cells. Autophagy 8(12):1798–810. doi:10.4161/auto.22110
Levine B, Kroemer G (2008) Autophagy in the pathogenesis of disease. Cell 132(1):27–42. doi:10.1016/j.cell.2007.12.018
Mizushima N (2007) Autophagy: process and function. Genes Dev 21(22):2861–2873. doi:10.1101/gad.1599207
Corradetti MN, Guan KL (2006) Upstream of the mammalian target of rapamycin: do all roads pass through mTOR? Oncogene 25(48):6347–6360. doi:10.1038/sj.onc.1209885
He C, Klionsky DJ (2009) Regulation mechanisms and signaling pathways of autophagy. Annu Rev Genet 43:67–93. doi:10.1146/annurev-genet-102808-114910
Shintani T, Klionsky DJ (2004) Autophagy in health and disease: a double-edged sword. Science 306(5698):990–995. doi:10.1126/science.1099993
White E, DiPaola RS (2009) The double-edged sword of autophagy modulation in cancer. Clin Cancer Res 15(17):5308–5316. doi:10.1158/1078-0432.CCR-07-5023
Kroemer G, Levine B (2008) Autophagic cell death: the story of a misnomer. Nat Rev Mol Cell Biol 9(12):1004–1010. doi:10.1038/nrm2529
Madeo F, Tavernarakis N, Kroemer G (2010) Can autophagy promote longevity? Nat Cell Biol 12(9):842–846. doi:10.1038/ncb0910-842
Marino G, Madeo F, Kroemer G (2011) Autophagy for tissue homeostasis and neuroprotection. Curr Opin Cell Biol 23(2):198–206. doi:10.1016/j.ceb.2010.10.001
Michallet AS, Mondiere P, Taillardet M, Leverrier Y, Genestier L, Defrance T (2011) Compromising the unfolded protein response induces autophagy-mediated cell death in multiple myeloma cells. PLoS One 6(10):e25820. doi:10.1371/journal.pone.0025820
Chan LL, Shen D, Wilkinson AR, Patton W, Lai N, Chan E, Kuksin D, Lin B, Qiu J (2012) A novel image-based cytometry method for autophagy detection in living cells. Autophagy 8(9):1371–1382. doi:10.4161/auto.21028
Seglen PO, Gordon PB (1982) 3-Methyladenine: specific inhibitor of autophagic/lysosomal protein degradation in isolated rat hepatocytes. Proc Natl Acad Sci U S A 79(6):1889–1892
Pliyev BK, Menshikov M (2012) Differential effects of the autophagy inhibitors 3-methyladenine and chloroquine on spontaneous and TNF-alpha-induced neutrophil apoptosis. Apoptosis 17(10):1050–1065. doi:10.1007/s10495-012-0738-x
Kumar S (2007) Caspase function in programmed cell death. Cell Death Differ 14(1):32–43. doi:10.1038/sj.cdd.4402060
Hanahan D, Weinberg RA (2000) The hallmarks of cancer. Cell 100(1):57–70
Guertin DA, Sabatini DM (2007) Defining the role of mTOR in cancer. Cancer Cell 12(1):9–22. doi:10.1016/j.ccr.2007.05.008
Takeuchi H, Kondo Y, Fujiwara K, Kanzawa T, Aoki H, Mills GB, Kondo S (2005) Synergistic augmentation of rapamycin-induced autophagy in malignant glioma cells by phosphatidylinositol 3-kinase/protein kinase B inhibitors. Cancer Res 65(8):3336–3346. doi:10.1158/0008-5472.CAN-04-3640
Jung CH, Ro SH, Cao J, Otto NM, Kim DH (2010) mTOR regulation of autophagy. FEBS Lett 584(7):1287–1295. doi:10.1016/j.febslet.2010.01.017
Ogier-Denis E, Pattingre S, El Benna J, Codogno P (2000) Erk1/2-dependent phosphorylation of Galpha-interacting protein stimulates its GTPase accelerating activity and autophagy in human colon cancer cells. J Biol Chem 275(50):39090–39095. doi:10.1074/jbc.M006198200
Pattingre S, Bauvy C, Codogno P (2003) Amino acids interfere with the ERK1/2-dependent control of macroautophagy by controlling the activation of Raf-1 in human colon cancer HT-29 cells. J Biol Chem 278(19):16667–16674. doi:10.1074/jbc.M210998200
Cagnol S, Chambard JC (2010) ERK and cell death: mechanisms of ERK-induced cell death—apoptosis, autophagy and senescence. FEBS J 277(1):2–21. doi:10.1111/j.1742-4658.2009.07366.x
Park MY, Kim DR, Jung HW, Yoon HI, Lee JH, Lee CT (2010) Genetic immunotherapy of lung cancer using conditionally replicating adenovirus and adenovirus-interferon-beta. Cancer Gene Ther 17(5):356–364. doi:10.1038/cgt.2009.78
Vitale G, Zappavigna S, Marra M, Dicitore A, Meschini S, Condello M, Arancia G, Castiglioni S, Maroni P, Bendinelli P, Piccoletti R, van Koetsveld PM, Cavagnini F, Budillon A, Abbruzzese A, Hofland LJ, Caraglia M (2012) The PPAR-gamma agonist troglitazone antagonizes survival pathways induced by STAT-3 in recombinant interferon-beta treated pancreatic cancer cells. Biotechnol Adv 30(1):169–184. doi:10.1016/j.biotechadv.2011.08.001
Olson MV, Lee J, Zhang F, Wang A, Dong Z (2006) Inducible nitric oxide synthase activity is essential for inhibition of prostatic tumor growth by interferon-beta gene therapy. Cancer Gene Ther 13(7):676–685. doi:10.1038/sj.cgt.7700941
Paty DW, Li DK (1993) Interferon beta-1b is effective in relapsing-remitting multiple sclerosis. II. MRI analysis results of a multicenter, randomized, double-blind, placebo-controlled trial. UBC MS/MRI Study Group and the IFNB Multiple Sclerosis Study Group. Neurology 43(4):662–667
Ruotsalainen J, Martikainen M, Niittykoski M, Huhtala T, Aaltonen T, Heikkila J, Bell J, Vaha-Koskela M, Hinkkanen A (2012) Interferon-beta sensitivity of tumor cells correlates with poor response to VA7 virotherapy in mouse glioma models. Mol Ther 20(8):1529–1539. doi:10.1038/mt.2012.53
Paillas S, Causse A, Marzi L, de Medina P, Poirot M, Denis V, Vezzio-Vie N, Espert L, Arzouk H, Coquelle A, Martineau P, Del Rio M, Pattingre S, Gongora C (2012) MAPK14/p38alpha confers irinotecan resistance to TP53-defective cells by inducing survival autophagy. Autophagy 8(7):1098–112. doi:10.4161/auto.20268
Kong D, Ma S, Liang B, Yi H, Zhao Y, Xin R, Cui L, Jia L, Liu X (2012) The different regulatory effects of p53 status on multidrug resistance are determined by autophagy in ovarian cancer cells. Biomed Pharmacother 66(4):271–278. doi:10.1016/j.biopha.2011.12.002
Sun J, Desai MM, Soong L, Ou JH (2011) IFN-alpha/beta and autophagy: tug-of-war between HCV and the host. Autophagy 7(11):1394–1396. doi:10.4161/auto.7.11.17514
Desai MM, Gong B, Chan T, Davey RA, Soong L, Kolokoltsov AA, Sun J (2011) Differential, type I interferon-mediated autophagic trafficking of hepatitis C virus proteins in mouse liver. Gastroenterology 141(2):674–685. doi:10.1053/j.gastro.2011.04.060, 685 e671-676
Liang C (2010) Negative regulation of autophagy. Cell Death Differ 17(12):1807–1815. doi:10.1038/cdd.2010.115
Lomonaco SL, Finniss S, Xiang C, Lee HK, Jiang W, Lemke N, Rempel SA, Mikkelsen T, Brodie C (2011) Cilengitide induces autophagy-mediated cell death in glioma cells. Neuro Oncol 13(8):857–865. doi:10.1093/neuonc/nor073
Kondo Y, Kanzawa T, Sawaya R, Kondo S (2005) The role of autophagy in cancer development and response to therapy. Nat Rev Cancer 5(9):726–734. doi:10.1038/nrc1692
Sivaprasad U, Basu A (2008) Inhibition of ERK attenuates autophagy and potentiates tumour necrosis factor-alpha-induced cell death in MCF-7 cells. J Cell Mol Med 12(4):1265–1271. doi:10.1111/j.1582-4934.2008.00282.x
Acknowledgments
This work was supported by Shanghai Science and Technology Funds (11431920104, 09XD1421800), National Science and Technology Major Project for Drug Discovery of Ministry of Science and Technology of China (2011ZX09102-001-27), and the National Key Basic Research Program of China (2013CB932502).
Conflict of Interest
None.
Author information
Authors and Affiliations
Corresponding author
Additional information
Y.L. and H.Z. contributed equally to this work.
Rights and permissions
About this article
Cite this article
Li, Y., Zhu, H., Zeng, X. et al. Suppression of Autophagy Enhanced Growth Inhibition and Apoptosis of Interferon-β in Human Glioma Cells. Mol Neurobiol 47, 1000–1010 (2013). https://doi.org/10.1007/s12035-013-8403-0
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12035-013-8403-0